as on February 4, 2026 at 4:01 pm IST
Day's Low
Day's High
11.59%
Downside
11.11%
Upside
52 Week's Low
52 Week's High
11.59%
Downside
154.11%
Upside
as on February 4, 2026 at 4:01 pm IST
Market Cap
₹15.76 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
-9.9
Return on capital employed (ROCE)
0Industry PE ratio
45.37
Beta (LTM)
0.27
P/B Ratio
-3.35
Dividend Yield
0PEG Ratio
58.26
Quarterly Earnings Growth YOY
457.14
EPS (TTM)
-0.09
Sector
Healthcare
Book Value
1.32
Technical Analysis
Bearish
View Technical Analysis
as on February 4, 2026 at 4:01 pm IST
Transgene Biotek in the last 5 years
Lowest (-227.67x)
December 31, 2024
Today (-9.90x)
February 3, 2026
Industry (45.37x)
February 3, 2026
Highest (13.23x)
October 8, 2018
Today’s Price to Earnings Ratio: -9.90x
Compare market cap, revenue, PE, and other key metrics of Transgene Biotek with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 15.76 | -9.57% | 0.96 | -1 | NA | |
| NA | 186.97 | -6.11% | 0.00 | 3 | 22 | |
| NA | 101.46 | 1.93% | 0.65 | -2 | 46 | |
| BUY | 6,206.51 | 5.42% | 0.53 | 90 | 687 | |
| NA | 13.87 | -17% | 0.93 | -14 | 1 |
Get share price movements and forecasts by analysts on Transgene Biotek.
Source: S&P Global Market Intelligence
Search interest for Transgene Biotek Ltd Stock has decreased by -51% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Transgene Biotek.
Transgene Biotek Ltd’s net profit fell -457.14% since last year same period to ₹0.39Cr in the Q2 2025-2026. On a quarterly growth basis, Transgene Biotek Ltd has generated 9.3% jump in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 3 quarters, -0.71 Cr → -0.39 Cr (in ₹), with an average increase of 37.7% per quarter
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 21.68% of holdings in Dec 2025 quarter
Against Peers
![]()
In the last 1 year, Take Solutions Ltd has given 260.8% return, outperforming this stock by 314.7%
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 70.04% of holdings in Dec 2025 quarter
Against Peers
![]()
In the last 3 years, Vimta Labs Ltd has given 165.7% return, outperforming this stock by 192.7%
Price Dip
![]()
In the last 1 month, Transgene Biotek stock has moved down by -29.5%
Revenue Fall
![]()
Revenue is down for the last 3 quarters, 0.12 Cr → 0.05 Cr (in ₹), with an average decrease of 29.2% per quarter
| Organisation | Transgene Biotek Ltd |
| Industry | Healthcare |
| CEO | K Koteswara Rao |
| E-voting on shares | Click here to vote |
Transgene Biotek share price today stands at ₹2.07 as on at the close of the market. Transgene Biotek share today touched a day high of ₹2.3 and a low of ₹1.83.
Transgene Biotek touched a 52 week high of ₹5.26 and a 52 week low of ₹1.83. Transgene Biotek share price today i.e. is closed at ₹2.07, which is -60.65% down from its 52 week high and 13.11% up from its 52 week low.
Transgene Biotek market capitalisation is ₹15.76 Cr as on .
To buy Transgene Biotek shares, you need to follow these steps:
Transgene Biotek trading volume is 4.77L as on . This means that 4.77L shares of Transgene Biotek were bought and sold on the stock market during today's trading session.